← SynDRA
BENAZEPRIL
SynDRA canonical compound SYN0002138 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | ACE |
| Mechanism of action | Angiotensin converting enzyme inhibitor |
| Indication | hypertension |
| Disease area | cardiology |
All known targets
Mechanisms of action (all sources)
- ACE inhibitor
- SLC33A1 INHIBITOR
Drug classes
- Angiotensin-converting Enzyme Inhibitors
- Angiotensin Converting Enzyme Inhibitor
- Angiotensin-Converting Enzyme Inhibitors
- Antihypertensive Agents
- Cardiovascular Agents
- Enzyme Inhibitors
- Protease Inhibitors
ATC classes
- C09A · ACE INHIBITORS, PLAIN
- ACE INHIBITORS, COMBINATIONS
Cross-references
Synonyms
- cibacen
- benazepril hydrochloride
- benazepril HCl
- Benazepril sandoz
- Briem
- Cibacen ws
- Cibacene
- Forteekor
- Lotrel
- C09AA07
- CGS-14824A
- Benazapril
- Benazeprilum
- Benzazepril
- Benazepril Sandoz
- Benazeprilum [Latin]
- Forteekor [veterinary]
- Benazepril (INN)
- Benazepril Sandoz (TN)
- Benazepril [INN:BAN]
- Forteekor [veterinary] (TN)
- Fortekor (TN)
- Lotensin (TN)
- CGS-14824-A
- [(3S)-3-{[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid
- [(3S)-3-({(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}amino)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid
- [(3S)-3-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid
- 2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid
- benazepril (ema epar veterinary)
- UDM7Q7QWP8
- CHEBI:3011
- Benazeprilum (Latin)
- benazapril
- benzazepril
- RefChem:54434
- DTXCID602645
- MFCD00864466
- BENAZEPRIL [INN]
Reported adverse events
- Stevens-Johnson syndrome
- Anaphylactoid reaction
- Hypotension
- Fatigue
- Nausea
- Thrombocytopenia
- Dizziness
- Cough
- Anxiety
- Headache
- Insomnia
- Flushing
Look up BENAZEPRIL in the interactive SynDRA portal →